Omthera Pharmaceuticals Priced, Nasdaq: OMTH
Has developed a prescription fish oil capsule that reduces triglyceride levels.
Industry: Health Care
First Day Return: -7.1%
Industry: Health Care
OMTH
Has developed a prescription fish oil capsule that reduces triglyceride levels.
| IPO Data | |
|---|---|
| IPO File Date | 03/11/2013 |
| Offer Price | $8.00 |
| Price Range $12.00 - $14.00 | |
| Offer Shares (mm) | 8.0 |
| Deal Size ($mm) | $64 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 04/10/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $64 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Princeton, NJ, United States |
| Founded | 2008 |
| Employees at IPO | 14 |
| Website www.omthera.com | |
IPO News for Omthera Pharmaceuticals
Omthera Pharmaceuticals (OMTH) Performance
